"Care of the elderly has become its own science and is very different in virtually everything than is the care of a typical middle-aged adult. This is important for ITP." — James Bussel, MD Reflecting ...

Several areas of discordance were observed, including contributing causes for delay in diagnosis, with patients perceiving extended wait times as a significant contributing factor. Patients were ...

Stimulating platelet production with romiplostim is an effective strategy for managing patients with ITP. Thrombocytopenias can be caused by increased platelet destruction, decreased platelet ...

A panelist discusses how ITP diagnosis remains one of exclusion requiring thorough testing to rule out other causes of thrombocytopenia, followed by patient education about autoimmune diseases and ...

Novartis announced that the Food and Drug Administration (FDA) has approved Promacta (eltrombopag) for the treatment of thrombocytopenia in children aged ≥6 years with chronic immune thrombocytopenia ...

DEAR DR. ROACH: What can you tell me about the cause and treatment of immune thrombocytopenia purpura (ITP)? I am a 71-year-old male, and after lab results showed a low blood platelet count, I ...

Immune thrombocytopenia (ITP) is a chronic autoimmune disorder associated with platelet destruction and increased bleeding risk, substantial economic burden, and impairment of health-related quality ...

STOCKHOLM, March 12, 2021 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO: SOBI) today announces that the first patient has been dosed with avatrombopag, a thrombopoietin receptor ...

Credit: Getty Images. The patient, who was initially diagnosed with Gaucher disease type 1 during her first pregnancy 20 years prior, presented with bleeding, hematomas, and thrombocytopenia, in ...

In this retrospective analysis, responses persisted with hydroxychloroquine treatment. Results of a study suggest treatment using hydroxychloroquine (HCQ) for immune thrombocytopenia (ITP) related to ...